| Helvepharm AG - Rivastigmin Zentiva Patch 9.5 mg/24 h, transdermales Pflaster |
| 62917 | | 02 | | Rivastigmin Zentiva Patch 9.5 mg/24 h | | transdermales Pflaster | | N06DA03 | | Rivastigmin | | 27.03.2014 | | |
|
| Composition |
| rivastigminum 13.8 mg, excipiens ad praeparationem pro 9.2 cm² cum liberatione 9.5 mg/24h. |
| Packungsbestandteile |
| Timbre transdermique | | | | | | | | Principe actif | Concentr. |
|---|
| Rivastigmine | 13.8 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Rivastigmine | 13.8 mg |
|
|
|
